Drugmakers kick off 2021 with 500 U.S. price hikes
NEW YORK (Reuters) – Drugmakers including Abbvie Inc and Bristol Myers Squibb raised U.S. list prices on more than 500 drugs to kick off 2021, according to an analysis by health care research firm 46brooklyn. The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced […]